A detailed history of Davenport & CO LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Davenport & CO LLC holds 11,532 shares of BNTX stock, worth $923,597. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,532
Previous 11,406 1.1%
Holding current value
$923,597
Previous $1.2 Million 11.64%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$88.96 - $112.35 $11,208 - $14,156
126 Added 1.1%
11,532 $1.06 Million
Q4 2023

Jan 23, 2024

BUY
$90.91 - $112.75 $1.04 Million - $1.29 Million
11,406 New
11,406 $1.2 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.